LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer

Background To investigate the mechanism and prognostic value of LINC01094 in cervical cancer (CC).Methods This study included 113 patients with CC. Their cervical tumour tissues and tumour-free cervical tissues were collected, with patient follow-up for a five-year prognostic period. Reverse transcr...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenhui Zhang, Wei Shang, Jinwei Cao, Huijuan Zhao
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Obstetrics and Gynaecology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/01443615.2025.2522866
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850099418339999744
author Wenhui Zhang
Wei Shang
Jinwei Cao
Huijuan Zhao
author_facet Wenhui Zhang
Wei Shang
Jinwei Cao
Huijuan Zhao
author_sort Wenhui Zhang
collection DOAJ
description Background To investigate the mechanism and prognostic value of LINC01094 in cervical cancer (CC).Methods This study included 113 patients with CC. Their cervical tumour tissues and tumour-free cervical tissues were collected, with patient follow-up for a five-year prognostic period. Reverse transcription-quantitative PCR (RT-qPCR) was used to identify LINC01094 and measure miR-1266-5p expression, Kaplan–Meier curves were used to predict patient survival, and multivariate Cox regression analysis revealed the factors affecting CC prognosis. A dual luciferase reporter (DLR) assay was performed to verify the targeting relationship of reciprocal genes. The Cell Counting Kit-8 (CCK8) assay was used to measure cell proliferation, and the Transwell recorded cell migration and invasion.Results Lower LINC01094 expression and higher level of miR-1266-5p expression were detected in-tumour tissues than in the tumour-free cervical tissues, with a negative correlation. Low LINC01094 expression, International Federation of Gynaecology and Obstetrics (FIGO) stage, and lymph node metastasis were identified as risk factors for CC prognosis, LINC01094 downregulation predicted higher patient mortality. The DLR assay identified miR-1266-5p as a possible target gene of LINC01094. Additional experiments revealed miR-1266-5p downregulation and decreased cell proliferation, migration and invasion of CC cells transfected with oe-LINC01094. These effects were restored after co-transfection with miR-mimic.Conclusions Low LINC01094 expression in patient with CC is a risk factor for prognosis. Overexpression of LINC01094 targeting miR-1266-5p prevents the progression of CC neoplasm.
format Article
id doaj-art-ef9f29d3f1e446068284ad9084ee62ca
institution DOAJ
issn 0144-3615
1364-6893
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Obstetrics and Gynaecology
spelling doaj-art-ef9f29d3f1e446068284ad9084ee62ca2025-08-20T02:40:29ZengTaylor & Francis GroupJournal of Obstetrics and Gynaecology0144-36151364-68932025-12-0145110.1080/01443615.2025.2522866LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancerWenhui Zhang0Wei Shang1Jinwei Cao2Huijuan Zhao3Department of Medical Imaging, The Third Hospital of Shijiazhuang, Shijiazhuang, ChinaDepartment of Obstetrics and Gynecology, Renqiu People’s Hospital, Renqiu, ChinaDepartment of Medical Imaging, The Sixth Hospital of Shijiazhuang, Shijiazhuang, ChinaSecond Department of Obstetrics and Gynecology, The Sixth Hospital of Shijiazhuang, Shijiazhuang, ChinaBackground To investigate the mechanism and prognostic value of LINC01094 in cervical cancer (CC).Methods This study included 113 patients with CC. Their cervical tumour tissues and tumour-free cervical tissues were collected, with patient follow-up for a five-year prognostic period. Reverse transcription-quantitative PCR (RT-qPCR) was used to identify LINC01094 and measure miR-1266-5p expression, Kaplan–Meier curves were used to predict patient survival, and multivariate Cox regression analysis revealed the factors affecting CC prognosis. A dual luciferase reporter (DLR) assay was performed to verify the targeting relationship of reciprocal genes. The Cell Counting Kit-8 (CCK8) assay was used to measure cell proliferation, and the Transwell recorded cell migration and invasion.Results Lower LINC01094 expression and higher level of miR-1266-5p expression were detected in-tumour tissues than in the tumour-free cervical tissues, with a negative correlation. Low LINC01094 expression, International Federation of Gynaecology and Obstetrics (FIGO) stage, and lymph node metastasis were identified as risk factors for CC prognosis, LINC01094 downregulation predicted higher patient mortality. The DLR assay identified miR-1266-5p as a possible target gene of LINC01094. Additional experiments revealed miR-1266-5p downregulation and decreased cell proliferation, migration and invasion of CC cells transfected with oe-LINC01094. These effects were restored after co-transfection with miR-mimic.Conclusions Low LINC01094 expression in patient with CC is a risk factor for prognosis. Overexpression of LINC01094 targeting miR-1266-5p prevents the progression of CC neoplasm.https://www.tandfonline.com/doi/10.1080/01443615.2025.2522866LINC01094cervical cancermiR-1266-5pprognosismalignantprogression
spellingShingle Wenhui Zhang
Wei Shang
Jinwei Cao
Huijuan Zhao
LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer
Journal of Obstetrics and Gynaecology
LINC01094
cervical cancer
miR-1266-5p
prognosis
malignant
progression
title LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer
title_full LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer
title_fullStr LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer
title_full_unstemmed LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer
title_short LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer
title_sort linc01094 targets mir 1266 5p to halt neoplasm progression of cervical cancer
topic LINC01094
cervical cancer
miR-1266-5p
prognosis
malignant
progression
url https://www.tandfonline.com/doi/10.1080/01443615.2025.2522866
work_keys_str_mv AT wenhuizhang linc01094targetsmir12665ptohaltneoplasmprogressionofcervicalcancer
AT weishang linc01094targetsmir12665ptohaltneoplasmprogressionofcervicalcancer
AT jinweicao linc01094targetsmir12665ptohaltneoplasmprogressionofcervicalcancer
AT huijuanzhao linc01094targetsmir12665ptohaltneoplasmprogressionofcervicalcancer